
What happened
GRAIL, Inc. (NASDAQ: GRAL) said Joshua J. Ofman sold 20,000 shares on 2026-10-15. Ofman is chief executive officer and a director. The shares sold at prices from $133.12 to $138.79 per share.
The Form 4 says the trades totaled about $2.74 million. After the sale, Ofman held 342,271 shares.
The filing also says the trades were made under a Rule 10b5-1 trading plan adopted on December 2, 2025. The company filed the Form 4 on 2026-10-16.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Shares sold | 20,000 shares | SEC Form 4 | |
| Sale proceeds | about $2.74 million | SEC Form 4 | |
| Shares held after sale | 342,271 shares | SEC Form 4 | |
| Sale price range | $133.12 to $138.79 per share | SEC Form 4 | |
| Sold as share of prior holding | 5.5% | Calculated from SEC Form 4 |
Read more: GRAIL (GRAL) stock analysis and investment case
Why it matters
OptimistFi's case is that GRAIL's value still turns on Galleri becoming the regulated, reimbursed standard for multi-cancer early detection before funding needs dilute the story. This filing does not change that operating thesis.
OptimistFi's calculation shows the 20,000 shares were about 5.5% of Ofman's prior holding before the trade. That lowers his stake, but he still held 342,271 shares afterward.
The filing also gives investors clear facts. Ofman is chief executive officer and a director. The sale took place on 2026-10-15. The shares traded in a range from $133.12 to $138.79.
The reported proceeds were about $2.74 million. The filing also says the plan was adopted on December 2, 2025. That is the strongest reason not to read the sale as a fresh opinion on the business.
It is also a sale, not a buy. So the direct effect is a smaller reported stake, even though Ofman still held a large position afterward. For investors, that makes the filing a mixed ownership signal rather than a direct read on Galleri.
Stock perps: every US stock that trades as a perpetual future, by leverage, live
What's next
The next Form 4 filing is the key follow-up. It will show whether Ofman's ownership changes again.
A further sale would extend the decline in reported holdings. A pause would leave 342,271 shares as the current reference point.
That next filing is the main dated update investors can check against this one. Until then, the post-sale stake is the nearest benchmark in the record.
More from OptimistFi
- GRAL stock: the GRAIL thesis, its status and the next test to watch
- Stock research on every company OptimistFi covers
From OptimistFi Perps
- Perp funding rates live: what longs and shorts pay on every venue
- Stock perps vs tokenized stocks: how US shares trade around the clock
- Weekend market prices: US stock indexes, gold and oil now
- Perps news: leveraged stocks, gold, FX and crypto on-chain
- Prop firms that fund crypto and stock perps traders: rules, prices and payouts
- Top perps movers today: stocks, commodities, FX and indices
Sources
- SEC Form 4 — Form 4 filed for GRAIL, Inc. reporting Joshua J. Ofman sales on 2026-10-15 and filed 2026-10-16.
Read the full OptimistFi thesis on GRAIL, Inc.: https://optimistfi.com/stocks/GRAL
See what would break the GRAIL, Inc. thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full GRAIL, Inc. investment case, its status and the next test to watch live on the GRAIL, Inc. thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
